Literature DB >> 12374800

Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.

Csilla Ozvegy1, András Váradi, Balázs Sarkadi.   

Abstract

The overexpression of the human ATP-binding cassette half-transporter, ABCG2 (placenta-specific ABC transporter, mitoxantrone resistance-associated protein, breast cancer resistance protein), causes multidrug resistance in tumor cells. An altered drug resistance profile and substrate recognition were suggested for wild-type ABCG2 and its mutant variants (R482G and R482T); the mutations were found in drug-selected tumor cells. In order to characterize the different human ABCG2 transporters without possible endogenous dimerization partners, we expressed these proteins and a catalytic center mutant (K86M) in Sf9 insect cells. Transport activity was followed in intact cells, whereas the ATP binding and hydrolytic properties of ABCG2 were studied in isolated cell membranes. We found that the K86M mutant had no transport or ATP hydrolytic activity, although its ATP binding was retained. The wild-type ABCG2 and its variants, R482G and R482T, showed characteristically different drug and dye transport activities; mitoxantrone and Hoechst 33342 were transported by all transporters, whereas rhodamine 123 was only pumped by the R482G and R482T mutants. In each case, ABCG2-dependent transport was blocked by the specific inhibitor, fumitremorgin C. A relatively high basal ABCG2-ATPase, inhibited by fumitremorgin C, was observed in all active proteins, but specific drug stimulation could only be observed in the case of R482G and R482T mutants. We found that ABCG2 is capable of a vanadate-dependent adenine nucleotide trapping. Nucleotide trapping was stimulated by the transported compounds in the R482G and R482T variants but not in the wild-type ABCG2. These experiments document the applicability of the Sf9 expression system for parallel, quantitative examination of the specific transport and ATP hydrolytic properties of different ABCG2 proteins and demonstrate significant differences in their substrate interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374800     DOI: 10.1074/jbc.M207857200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study.

Authors:  Anna Jacobs; Dana Emmert; Svenja Wieschrath; Christine A Hrycyna; Michael Wiese
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

Review 2.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

3.  Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution.

Authors:  Jin Wang; Fang Sun; Da-wei Zhang; Yongming Ma; Fang Xu; Jitendra D Belani; Jonathan C Cohen; Helen H Hobbs; Xiao-Song Xie
Journal:  J Biol Chem       Date:  2006-07-25       Impact factor: 5.157

4.  Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8.

Authors:  Jin Wang; Da-Wei Zhang; Ying Lei; Fang Xu; Jonathan C Cohen; Helen H Hobbs; Xiao-Song Xie
Journal:  Biochemistry       Date:  2008-04-11       Impact factor: 3.162

5.  The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding.

Authors:  Karin F K Ejendal; Ndeye Khady Diop; Linda C Schweiger; Christine A Hrycyna
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

6.  Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

Authors:  Yimao Zhang; Youngjoo Byun; Yunzhao R Ren; Jun O Liu; John Laterra; Martin G Pomper
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

7.  Glutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactor.

Authors:  Runying Yang; Yue-xian Hou; Chase A Campbell; Kanagaraj Palaniyandi; Qing Zhao; Andrew J Bordner; Xiu-bao Chang
Journal:  Biochim Biophys Acta       Date:  2011-02-26

8.  A single intact ATPase site of the ABC transporter BtuCD drives 5% transport activity yet supports full in vivo vitamin B12 utilization.

Authors:  Nir Tal; Elena Ovcharenko; Oded Lewinson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-19       Impact factor: 11.205

9.  A distinct mechanism for the ABC transporter BtuCD-BtuF revealed by the dynamics of complex formation.

Authors:  Oded Lewinson; Allen T Lee; Kaspar P Locher; Douglas C Rees
Journal:  Nat Struct Mol Biol       Date:  2010-02-21       Impact factor: 15.369

10.  A new ABC half-transporter in Leishmania major is involved in resistance to antimony.

Authors:  J I Manzano; R García-Hernández; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.